Program and Workshops
|
|
||
Wednesday, March 7 |
||
|
||
8:00am | Registration for Gambro Hands-On Workshop | |
9:00am-4:30pm | H01 Gambro Prismaflex Hands-On Workshop | |
(this workshop has reached maximum enrollment, please consider the slightly condensed version, Workshop H03, on Saturday afternoon.) | ||
9:00-10:30am | Session 1 | |
10:30-10:45 | Coffee Break | |
10:45-12:15 | Session 2 | |
12:15-1:15 | Lunch Hosted by Conference for Workshop Participants | |
1:15-2:45 | Session 3 | |
2:45-3:00 | Coffee Break | |
3:00-4:30 | Session 4 | |
5:30pm-8:00 pm | Conference Registration | |
|
||
Thursday Morning, March 8 |
||
|
||
7:00am-7:30pm | Registration | |
8:00am-4:15pm | WORKSHOPS | |
(open to all participants - applicable to physicians, nurses and allied personnel) (Codes: C= Core workshop, I = Intermediate, A = Advanced, N= Nurses, AP = of interest to nurses and allied personnel) Workshops designated by an asterisk (*) will be presented twice in different time slots. Workshops presented in a series are marked with a 1 for a primary workshop discussion in this area and 2 for a more complex or advanced discussion in this area. Please note that the series workshops 1 and 2 can be either taken subsequently (following each other) or they can each be taken independently (e.g. workshop 1 can be taken without taking workshop 2 and vice versa). | ||
Workshop Group 1 | ||
8:00-9:30 | ||
8:00-9:30 | A01 CRRT Systems I - I. B. Braun Diapact II | |
Please describe the key features of your device and the different modalities supported. Describe the safety features of your machine. Discuss how your device supports various applications for extracorporeal support for renal and non-renal indications. Hands on demonstrations are welcome. | ||
8:00-9:30 | A01 II. Baxter - Edwards Lifescience Critical Care Nephrology Alliance Accura/Aquarius | |
Bev Ryan, RN Lee C. Ware, RN |
||
Device demonstrations of features, setup, operation, monitoring and discontinuation | ||
8:00-9:30 | B02 Dialysis Dose Prescription and Delivery 1 | |
William R. Clark, MD Mark R. Marshall, MBChB, FRACP Claudio Ronco, MD |
||
Operational characteristics influencing solute removal in IHD, PD and CRRT | ||
8:00-9:30 | C03 Vascular Access /Membrane and Circuit 1 | |
Ian Baldwin, RN, MN, PhD, ACCCN Michael A. Kraus, MD Maria T Pascual, RN BSN MPH |
||
Principles of catheter choice, placement, maintenance, recognition and management of complications, selection and use of membranes for different applications, circuit design, setup and monitoring | ||
8:00-9:30 | D04 Resuscitation 1 | |
Daniel Davis, MD Patty Graham, RN, MS, CCRN, CS |
||
Principles of reseuscitation for the critically il patient | ||
8:00-9:30 | E05 Pediatric CRRT: The Basics | |
Steven R. Alexander, MD Patrick D. Brophy, MD, FAAP, FRCPC Timothy E. Bunchman, MD Jordan M. Symons, MD |
||
Technique requirement and application for use in children including neonates | ||
8:00-9:30 | F06 Extracorporeal Techniques for Sepsis 1 | |
Patrick M. HonorČ, MD John A. Kellum, MD, FACP, FCCM, FCCP |
||
Pathophysiology of sepsis and rationale for use of extracorporeal support in treatment of sepsis. Experimental models for high permeability membranes, HVHF, VHVHF and hybrid therapies | ||
8:00-9:30 | G07 Plasma Exchange Therapy and Hybrid Techniques 1 | |
Arthur Bradwell, MD Andre A. Kaplan, MD Joerg Rammo, MD |
||
Principles of plasma exchange, sorbent based and hybrid therapies for extracorporeal support. Results from experimental models and human studies | ||
9:30-9:45 | Coffee Break | |
Workshop Group 2 | ||
9:45-11:15 | ||
9:45-11:15 | A08 CRRT Systems II - I. CHF Solutions | |
Device demonstrations of features, setup, operation, monitoring and discontinuation | ||
9:45-11:15 | A08 II. NxStage Therapy System | |
Device demonstrations of features, setup, operation, monitoring and discontinuation | ||
9:45-11:15 | B09 Anticoagulation 1: Mechanisms and Techniques | |
Andrew Davenport, MD, MA Oliver Joannes-Boyau, MD Ashita Tolwani, MD |
||
Anticoagulation regimens: Mechanisms, selection, prescription, monitoring and implementation | ||
9:45-11:15 | C10 Fluid Management 1 | |
Ravindra L. Mehta, MBBS, MD, DM, FACP Michael R. Pinsky, MD |
||
Principles of volume assessment, fluid removal and fluid regulation with different CRRT equipment | ||
9:45-11:15 | D11 Acid Base and Electrolyte Problems in the Critically Ill 1 | |
John A. Kellum, MD, FACP, FCCM, FCCP Richard Sterns, MD James A. Tumlin, MD |
||
Principles and diagnosis of comon acid base and electrolyte problems in the critically ill patient | ||
9:45-11:15 |
E12 Organizational Aspects of CRRT Programs 1: Development and Implementation |
|
Ian Baldwin, RN, MN, PhD, ACCCN Jorge Cerda, MD, FACP, FASN Rhonda K. Martin, RN, MS, MLT(ASCP) |
||
Practical issues for organization and implementation of a CRRT program. Developing and implementing policies and protocols for CRRT | ||
9:45-11:15 | F13 Heart Failure and Cardio-Renal Syndrome 1 | |
Inder S Anand, MD, FRCP, DPhil Giancarlo Marenzi, MD |
||
Pathophysiology, recognition and management strategies for cardiac and renal failure in the critically ill patient | ||
9:45-11:15 | G14 Therapy Comparisons I: SLED vs. CRRT vs. PD | |
Rajasekara Chakravarthi, MD, DNB (Nephrology) Thomas A. Golper, MD Mark R. Marshall, MBChB, FRACP |
||
Comparisons of operational characteristics including anticoagulation, membranes, solutions and flows and approaches for ongoing and future research | ||
11:15-12:45 | Lunch hosted by Conference | |
|
||
Thursday, Afternoon March 8 |
||
|
||
Workshop Group 3 | ||
12:45-2:15 | ||
12:45-2:15 | A15 CRRT Systems III - I. Gambro Prismaflex | |
Device demonstrations of features, setup, operation, monitoring and discontinuation | ||
12:45-2:15 | A15 II. Fresenius Systems | |
Device demonstrations of features, setup, operation, monitoring and discontinuation | ||
12:45-2:15 | B16 Solutions for CRRT 1 | |
Timothy E. Bunchman, MD Michael A. Kraus, MD Sheldon W. Tobe, MD, FRCP(C) |
||
Basic concepts for formulation and application of various solutions for pre-dilution, replacement and dialysate in critically ill patients | ||
12:45-2:15 | C17 Drug Management 1 | |
Bruce A. Mueller, Pharm.D., FCCP Miet Schetz, MD, PhD |
||
Dosing principles for critically ill patients and adjustments in extracorporeal support techniques | ||
12:45-2:15 | D18 Nutritional Assessment and Support 1 | |
Wilfred Druml, MD Martine Leblanc, MD |
||
Pathophysiology of malnutrition in critically ill patients. Principles of nutritional assessment and support | ||
12:45-2:15 | E19 A Systems-based Approach to CRRT 1 | |
Linda Awdishu, BSc Pharm Ravindra L. Mehta, MBBS, MD, DM, FACP |
||
Principles of systems based management strategies and their application to CRRT. Approaches to reduce errors in therapy prescription and delivery | ||
12:45-2:15 | F20 Liver and the Kidney 1 | |
Tarek Hassanein, MD Stefan Herget-Rosenthal, MD |
||
Pathophysiology of hepatic failure and rationale for use of different techniques for extracorporeal support techniques (Cell based systems, MARS, CRRT) for hepatic support | ||
12:45-2:15 | G21 Biomarkers 1 | |
Bertrand L. Jaber, MD Kathleen Liu, MD |
||
Principles and classification of biomarkers and their application for diagnosis and management of diseases. Criteria for using biomarkers as surrogate end points | ||
2:15-2:30 | Coffee Break | |
Workshop Group 4 | ||
2:30-4:00 | ||
2:30-4:00 | A22 CRRT Systems I - I. B. Braun Diapact | |
Device demonstrations of features, setup, operation, monitoring and discontinuation | ||
2:30-4:00 | A22 CRRT Systems I - II. Baxter - Edwards Lifesciences Critical Care Nephrology Alliance Accura/Aquarius | |
Bev Ryan, RN Lee C. Ware, RN |
||
Device demonstrations of features, setup, operation, monitoring and discontinuation | ||
2:30-4:00 | B23 Dialysis Dose Prescription and Delivery 2 | |
William R. Clark, MD Mark R. Marshall, MBChB, FRACP |
||
Case based discussions of prescription of dose, modality choice and optimal dose delivery to match the therapy to the patients need | ||
2:30-4:00 | C24 Vascular Access/Membrane and Circuit 2 | |
Ian Baldwin, RN, MN, PhD, ACCCN Michael A. Kraus, MD Maria T Pascual, RN BSN MPH |
||
Case based discussion of various factors influencing circuit longevity, membrane function and troubleshooting for problems encountered | ||
2:30-4:00 | D25 Resuscitation 2 | |
Daniel Davis, MD Patty Graham, RN, MS, CCRN, CS |
||
Case studies using SIM-Man for resuscitation scenarios | ||
2:30-4:00 |
E26 CRRT in the New Born: Principles and Application Nursing Issues in Pediatric CRRT |
|
Helen Currier, BSN, RN, CNN Jordan M. Symons, MD |
||
Practical issues for setting up and maintaining a pediatric CRRT program. Policies and procedures and protocol based management | ||
2:30-4:00 | F27 Extracorporeal Techniques for Sepsis 2 | |
Patrick M. HonorČ, MD Oliver Joannes-Boyau, MD Claudio Ronco, MD Ciro Tetta, MD |
||
Technical considerations and practical application of extracorporeal support techniques for sepsis. Results of human studies for use of high permeability membranes, HVHF, VHVHF and hybrid techniques for sepsis | ||
2:30-4:00 | G28 Plasma Exchange Therapy and Hybrid Techniques 2 | |
Arthur Bradwell, MD Andre A. Kaplan, MD Lei-shi Li, MD, FHKCP |
||
Case based discussion of practical application of plasma exchange, sorbent based and hybrid therapies for extracorporeal support | ||
SESSION I PATIENT CHARACTERISTICS |
||
4:30-7:00 | OPENING SESSION | |
4:30-4:35 | Opening Remarks | |
Ravindra L. Mehta, MBBS, MD, DM, FACP |
||
Plenary 1 MINI-SYMPOSIA Organ Dysfunction in the Critically Ill Patient |
||
4:30-7:00PM | ||
4:35-4:55 | Predicting Lung Injury: Which Markers | |
Kathleen Liu, MD |
||
4:55-5:15 | Cardio-Renal Syndrome | |
Inder S Anand, MD, FRCP, DPhil |
||
5:15-5:35 | Nutritional and Energy Requirements in Critical Illness | |
Wilfred Druml, MD |
||
5:35-5:55 | Mechanisms of Ischemic AKI | |
Mark D. Okusa, MD |
||
5:55-6:15 |
SPECIAL LECTURE Renal Effects of Critical Illness |
|
Michael R. Pinsky, MD |
||
6:15-6:35 |
Kidney Disease: Common, Harmful, Treatable Introducing "World Kidney Day" |
|
6:35-7:00 | Panel Discussion | |
7:00-8:30 pm | Welcome Reception and Poster Viewing and Exhibits Open | |
|
||
Friday Morning, March 9 |
||
|
||
7:00am-4:00pm | Registration | |
SESSION II: EMERGING CONCEPTS IN AKI AND CRITICAL CARE |
||
7:25-7:30 | Announcements | |
Ravindra L. Mehta, MBBS, MD, DM, FACP |
||
Plenary 2 MINI-SYMPOSIA Acute Kidney Injury (AKI): What's New? |
||
7:30-9:45AM | ||
7:30-7:50 | Metabolic Consequences of AKI | |
Jonathan Himmelfarb, MD |
||
7:50-8:05 | Genetic Determinants in AKI | |
Bertrand L. Jaber, MD |
||
8:05-8:20 | Pediatric AKI: Do Biomarkers Predict Injury? | |
Stuart L. Goldstein, MD |
||
8:20-8:35 | Recovery from AKI: Predictive Factors | |
Jonathan Himmelfarb, MD |
||
8:35-8:50 | Long Term Prognosis of Patients with AKI: Is Intensive Care Worth It? | |
Wilfred Druml, MD |
||
8:50-9:05 | Management of Cirrhotic Ascites: Can We Prevent AKI? | |
Mark D. Okusa, MD |
||
9:05-9:20 | Challenging Cases 1 | |
Richard Sterns, MD |
||
9:20-9:45 |
SPECIAL LECTURE: Acute Kidney Injury Network: A Strategy to Improve Outcomes from AKI |
|
Ravindra L. Mehta, MBBS, MD, DM, FACP |
||
9:45-10:00 | Panel Discussion | |
10:00-10:30 | Coffee Break | |
Plenary 3 MINI-SYMPOSIA Controversies in Management of the Critically Ill Patient |
||
10:30-12:45 | ||
10:30-10:50 | Targeted Resuscitation: Strategies for Success | |
Michael R. Pinsky, MD |
||
10:50-11:10 | Wet, Dry, and AKI: Just the FACTTs | |
Kathleen Liu, MD |
||
11:10-11:30 | Rapid Response Teams: Do They Save Lives? | |
Daniel Davis, MD |
||
11:30-11:45 | ELSO and PALISI Trials | |
James Fortenberry, MD |
||
11:45-12:00 | Infection Control in The ICU: An Update | |
Maria T Pascual, RN BSN MPH |
||
12:00-12:15 | Challenging Cases 2 | |
Lei-shi Li, MD, FHKCP |
||
12:15-12:45 |
SPECIAL LECTURE Acid-Base Physiology in Critically Ill Patients: Traditional vs Modern Approaches |
|
John A. Kellum, MD, FACP, FCCM, FCCP |
||
12:45-1:00 | Panel Discussion | |
1:00-2:15 | Lunch Hosted by Conference | |
|
||
Friday Afternoon, March 9 |
||
|
||
WORKSHOPS | ||
Workshop Group 5 | ||
2:15-3:45 | ||
2:15-3:45 | A29 CRRT Systems II - I. CHF Solutions | |
Device demonstrations of features, setup, operation, monitoring and discontinuation | ||
2:15-3:45 | A29 CRRT Systems II - II. NxStage Therapy System | |
Device demonstrations of features, setup, operation, monitoring and discontinuation | ||
2:15-3:45 | B30 Anticoagulation 2: Special Techniques Citrate | |
Noel Gibney, MD Ashita Tolwani, MD David M. Ward, MD, FRCP |
||
Comparison of various techniques for regional citrate anticoagulation including requirements, setup, monitoring and results | ||
2:15-3:45 | C31 Fluid Management 2 | |
Ravindra L. Mehta, MBBS, MD, DM, FACP Michael R. Pinsky, MD |
||
Case based discussion of application of techniques for fluid regulation in CRRT | ||
2:15-3:45 | D32 Acid Base and Electrolyte problems in the critically ill 2 | |
Jonathan Himmelfarb, MD John A. Kellum, MD, FACP, FCCM, FCCP Richard Sterns, MD |
||
Case studies of common problems and strategies for management including use of dialytic therapies including CRRT | ||
2:15-3:45 |
E33 Organizational Aspects of CRRT Programs 2: Development and Implementation |
|
Ian Baldwin, RN, MN, PhD, ACCCN Jorge Cerda, MD, FACP, FASN |
||
Case studies of proven techniques for growing and enhancing a CRRT program. Multidisciplinary teams, collaborative practice, Financial models and other strategies for success | ||
2:15-3:45 | F34 Heart Failure and Cardio-renal Syndrome 2 | |
Inder S Anand, MD, FRCP, DPhil Giancarlo Marenzi, MD |
||
Technical considerations, practical application and results of different methods to treat heart failure and cardio-renal syndrome | ||
2:15-3:45 | G35 Therapy Comparisons 2: SLED vs. CRRT vs. PD | |
Emmanuel Burdmann, MD, PhD Vijay Kher, MD Mark R. Marshall, MBChB, FRACP |
||
Case Based Examples of SLED (daily and Continuous), PD (intermittent, tidal) and practical aspects for recognizing and managing complications and approaches for ongoing and future research. | ||
3:45-4:00 | Coffee Break | |
Workshop Group 6 | ||
4:00-5:30 | ||
4:00-5:30 | A36 CRRT Systems III - I. Gambro Prisma | |
Device demonstrations of features, setup, operation, monitoring and discontinuation | ||
4:00-5:30 | A36 CRRT Systems III - II. Fresenius Systems | |
Device demonstrations of features, setup, operation, monitoring and discontinuation | ||
4:00-5:30 | B37 Solutions for CRRT 2 | |
Jeffrey F Barletta, PharmD, FCCM Timothy E. Bunchman, MD Edward Ross, MD Sheldon W. Tobe, MD, FRCP(C) |
||
Case based discussions of applications of solutions for acid-base and metabolic control, electrolyte and divalent ion homeostasis | ||
4:00-5:30 | C38 Drug Management 2 | |
Thomas A. Golper, MD Miet Schetz, MD, PhD |
||
Case based discussion of practical aspects for drug prescription, delivery and management of drug interactions in CRRT | ||
4:00-5:30 | D39 Nutritional Assessment and Support 2 | |
Wilfred Druml, MD Martine Leblanc, MD Bruce A. Mueller, Pharm.D., FCCP |
||
Case based discussion of technical and practical considerations for nutritional support with CRRT | ||
4:00-5:30 | E40 A Systems-based Approach to CRRT2 | |
Linda Awdishu, BSc Pharm Ravindra L. Mehta, MBBS, MD, DM, FACP |
||
Case studies of applications of systems based approaches for problem solving and continuous quality improvement in CRRT. Strategies to implement best practices to improve patient safety and outcomes. | ||
4:00-5:30 | F41 Liver and Kidney II: Hepatic Support | |
Andrew Davenport, MD, MA Stefan Herget-Rosenthal, MD Rhonda K. Martin, RN, MS, MLT(ASCP) |
||
Technical considerations, practical application and results of different methods of hepatic support for patients with hepatic failure and hepatorenal syndrome | ||
4:00-5:30 | G42 Biomarkers 2 | |
Kathleen Liu, MD Gunars E. Valkirs, PhD |
||
Applications for biomarkers as diagnostics and theranostics | ||
5:30pm | Adjourn | |
6:00-7:00pm | Meet the Faculty Reception | |
|
||
Saturday Morning, March 10 |
||
|
||
7:00am-5:00pm | Registration | |
SESSION III: TECHNIQUE CHARACTERISTICS |
||
7:25-7:30 | Announcements | |
Plenary 4 MINI-SYMPOSIA Challenges and Controversies in Renal Support and CRRT |
||
7:30-10:00 | ||
7:30-7:50 | Ultrafiltration for Heart Failure: What is the Evidence? | |
Giancarlo Marenzi, MD |
||
7:50-8:10 | Dose of Dialysis in CRRT: Results of a Randomized Controlled Trial | |
Ashita Tolwani, MD |
||
8:10-8:30 | Advances in Renal Support: What's New? | |
Noel Gibney, MD |
||
8:30-:8:45 |
Fluid Balance Errors with CRRT Machines: Should We Have Standards? |
|
Claudio Ronco, MD |
||
8:45-9:00 | Applying Pharmacodynamic Principles to CRRT Patients | |
Bruce A. Mueller, Pharm.D., FCCP |
||
9:00-9:15 | Challenging Cases 3 | |
Vijay Kher, MD |
||
9:15-9:45 |
SPECIAL LECTURE Debate Contrast Nephropathy: To Filter or Not? |
|
Giancarlo Marenzi, MD James A. Tumlin, MD |
||
9:45-10:00 | Panel Discussion | |
10:00-10:20 | Coffee Break | |
SESSION IV FUTURE TRENDS IN CRRT AND CRITICAL CARE |
||
Plenary 5 MINI SYMPOSIA Emerging Strategies in Extracorporeal Support |
||
10:20-12:50 |
Co-chair: Amit Varma, MD |
|
10:20-10:40 | Wearable Kidney: Does it Exist? | |
Claudio Ronco, MD |
||
10:40-11:00 | High cut off Membranes: Applications for Cancer | |
Arthur Bradwell, MD |
||
11:00-11:20 |
Diffusive Clearance of Cytokines in Sepsis? Fact or Fantasy? |
|
Ian Baldwin, RN, MN, PhD, ACCCN |
||
11:20-11:35 |
High Volume or High Permeability Membranes for Sepsis: Which Technique? |
|
Patrick M. HonorČ, MD |
||
11:35-11:50 |
SPECIAL LECTURE Looking to the Future: Applying Systems Biology to Extracorporeal Support |
|
John A. Kellum, MD, FACP, FCCM, FCCP |
||
11:50-12:10 | Liver Support Systems: Ready for Prime Time? | |
Stefan Herget-Rosenthal, MD |
||
12:10-12:35 | Challenging cases 4 | |
Emmanuel Burdmann, MD, PhD |
||
12:35-12:50 | Panel Discussion | |
12:50 | Closing Remarks | |
Ravindra L. Mehta, MBBS, MD, DM, FACP |
||
12:55:00 PM | Conference Adjourns | |
|
||
Elective Hands On Workshops |
||
|
||
12:45-1:45 | Lunch Hosted by Conference for Workshop Participants | |
1:00-5:00 | H02 Fresenius Workshop "SLED , EDD and CRRT with the K machines" | |
Learn how to use the Fresenius system for CRRT, SLED and EDD | ||
1:00-5:00 | H03 Gambro Prismaflex Hands-On Workshop (condensed version of H01) | |
This workshop has been added to handle the enrollment interest in H01. It will be a slightly condensed version of its original form presented on Wednesday. | ||
1:00-5:00 | H04 CHF Solutions "The Aquadex FlexFlow System" | |
Use of Aquapheresis and the Aquadex FlexFlow in fluid overload states. | ||
1:00-5:00 | H05 Pediatric Hands-on Workshop | |
Timothy E. Bunchman, MD Helen Currier, BSN, RN, CNN |
||
How to prescribe and deliver CRRT for neonates and pediatric patients, including machine set up, operations, monitoring and managing alarm conditions | ||
1:45-3:15 | Session 1 | |
3:15-3:30 | Coffee Break | |
3:30-5:00 | Session 2 | |
5:00 | Workshops Adjourn | |